{"id":301008,"date":"2019-11-01T23:30:40","date_gmt":"2019-11-02T06:30:40","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/11\/seneca-biopharma-and-jiangsu-qyuns-therapeutics-announce-development-plan-for-potential-joint-pipeline-at-7th-china-renaissance-healthcare-and-life-science-leadership-summit\/"},"modified":"2019-11-02T00:01:33","modified_gmt":"2019-11-02T07:01:33","slug":"seneca-biopharma%e8%81%94%e5%90%88%e4%b8%ad%e5%9b%bd%e4%bc%81%e4%b8%9a%e6%b7%b1%e8%80%95%e4%b8%ad%e5%9b%bd%e5%b8%82%e5%9c%ba","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/11\/seneca-biopharma%e8%81%94%e5%90%88%e4%b8%ad%e5%9b%bd%e4%bc%81%e4%b8%9a%e6%b7%b1%e8%80%95%e4%b8%ad%e5%9b%bd%e5%b8%82%e5%9c%ba\/","title":{"rendered":"\u53c8\u4e00\u5bb6\u516c\u53f8\u7784\u5411\u4e2d\u56fd\u5e02\u573a\uff0cSeneca Biopharma\u8054\u5408\u4e2d\u56fd\u4f01\u4e1a\u6df1\u8015\u4e2d\u56fd\u5e02\u573a"},"content":{"rendered":"<p>Seneca Biopharma, Inc.\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aSCNA\uff09\u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u9488\u5bf9\u672a\u6ee1\u8db3\u533b\u7597\u9700\u6c42\u7684\u75be\u75c5\u7684\u65b0\u7597\u6cd5\uff0c\u800c\u6c5f\u82cf\u8343\u4fe1\u751f\u7269\u533b\u836f\u6709\u9650\u516c\u53f8\uff08\u201c\u8343\u4fe1\u201d\uff09\u5219\u662f\u4e00\u5bb6\u4e13\u6ce8\u4e8e\u5355\u514b\u9686\u6297\u4f53\u7597\u6cd5\u7684\u4e2d\u56fd\u516c\u53f8\u3002\u53cc\u65b9\u5728\u4e00\u573a\u5cf0\u4f1a\u4e0a\u5ba3\u5e03\u4e86\u7528\u4e8e\u6cbb\u7597\u514d\u75ab\u6027\u75be\u75c5\u7684\u4ea7\u54c1\u8054\u5408\u4ea7\u54c1\u5f00\u53d1\u8ba1\u5212\u3002<\/p>\n<p>Seneca Biopharma, Inc.\u9996\u5e2d\u533b\u5b66\u5b98\u3001\u533b\u5b66\u535a\u58ebDavid Recker\u8868\u793a\uff1a\u201c\u8fd9\u79cd\u5019\u9009\u4ea7\u54c1\u6709\u53ef\u80fd\u5bf9\u591a\u79cd\u514d\u75ab\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u7684\u60a3\u8005\u7ed3\u679c\u4ea7\u751f\u79ef\u6781\u800c\u6301\u4e45\u7684\u5f71\u54cd\u3002SCA005 \/ QX005N\u5177\u6709\u6cbb\u7597\u54ee\u5598\u548c\u7279\u5e94\u6027\u76ae\u708e\u7684\u7279\u6b8a\u524d\u666f\u3002\u201d<\/p>\n<p>\u8343\u4fe1\u7684\u8d44\u4ea7\u5305\u62ec\u9488\u5bf9IL-4R\u03b1\u7684QX005N\u3001\u9488\u5bf9IL-17A\u7684QX002N\u3001\u9488\u5bf9IL-23A\u7684QX004N\u548c\u9488\u5bf9IFNR\u03b1\u7684QX006N\u3002\u4e24\u5bb6\u516c\u53f8\u671f\u671b\u5728\u5168\u7403\u8303\u56f4\u5185\u5171\u540c\u5f00\u53d1\u8fd9\u4e9b\u8d44\u4ea7\uff0c\u5e76\u5728\u672a\u6765\u7684\u4ea7\u54c1\u6269\u5c55\u65b9\u9762\u8fdb\u884c\u5408\u4f5c\u3002\u7b7e\u7f72\u8bb8\u53ef\u534f\u8bae\u540e\uff0cSeneca\u7684\u4e3b\u8981\u8d44\u4ea7\u5c06\u4e3aSNC005\uff08QX005N\uff09\uff0c\u5176\u9488\u5bf9IL-4R\u03b1\u7684\u76ee\u6807\u662f\u6cbb\u7597\u54ee\u5598\u548c\u7279\u5e94\u6027\u76ae\u708e\u3002<\/p>\n<p>\u8343\u4fe1\u9996\u5e2d\u8fd0\u8425\u5b98Yiliang Wu\u6307\u51fa\uff1a\u201c\u6211\u4eec\u7684\u5e73\u53f0\u5df2\u7ecf\u751f\u4ea7\u51fa\u516d\u79cd\u65b0\u9896\u7684\u5019\u9009\u836f\u7269\uff0c\u5b83\u4eec\u5904\u4e8e\u4e34\u5e8a\u524d\u548c\u4e34\u5e8a\u7814\u7a76\u7684\u4e0d\u540c\u9636\u6bb5\u3002\u8fd9\u79cd\u5408\u4f5c\u5173\u7cfb\u5c06\u4f7f\u6211\u4eec\u80fd\u591f\u5229\u7528Seneca\u4e16\u754c\u4e00\u6d41\u7ba1\u7406\u56e2\u961f\u7684\u7ecf\u9a8c\u6765\u52a0\u901f\u8fd9\u4e9b\u6709\u524d\u9014\u7684\u7597\u6cd5\u7684\u5168\u7403\u5546\u4e1a\u5316\u3002\u201d<\/p>\n<p>Seneca Biopharma, Inc.\uff08NASDAQ\uff1aSCNA\uff09\u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u9488\u5bf9\u672a\u6ee1\u8db3\u533b\u7597\u9700\u6c42\u7684\u75be\u75c5\u7684\u65b0\u578b\u7597\u6cd5\u3002Seneca\u6b63\u5728\u5bfb\u627e\u548c\u6536\u8d2d\u65b0\u8d44\u4ea7\u3001\u6709\u524d\u9014\u7684\u79d1\u5b66\u548c\u6280\u672f\uff0c\u8fd9\u4e9b\u65b0\u6280\u672f\u5c06\u4e3a\u60a3\u8005\u5e26\u6765\u6709\u610f\u4e49\u7684\u7597\u6cd5\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seneca Biopharma, Inc., (NASDAQ: SCNA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., a China-based company focused on monoclonal antibody therapeutics, jointly announce development plans for a joint pipeline of products for the treatment of immunological diseases<\/p>\n","protected":false},"author":9,"featured_media":300999,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-301008","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/301008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=301008"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/301008\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/300999"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=301008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=301008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=301008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}